News
WRN Chemical President and CEO discusses potential new technologies that can be used to combat COVID-19 with different pharmaceutical company representatives.
WRN Chemical is granted a Canadian patent for a chemical process that leads to high value oil and gas chemicals.
WRN Chemical awarded a United States patent for a new chemical process technology that leads to pharmaceutical analogues that can be made into a therapeutic that can treat and cure Type II Diabetes.
WRN Chemical President and CEO discusses equity offerings with Bank of Montreal financing executives.
WRN Chemical President and CEO meets with Amgen Venture Fund Director to discuss potential partnerships and venture funding.
WRN Chemical awarded a Canadian patent for a new process that can manufacture HIV therapeutics that can be used to treat and prevent infection.
WRN Chemical awarded a patent in Switzerland for a process that leads to an indene combinatorial library that can regulate insulin.
WRN Chemical awarded a patent in Switzerland for a chemical process that leads to high value agrochemicals.
WRN Chemical awarded a patent in Switzerland for an indene petroleum upgrading process that has a low environmental impact.
WRN Chemical awarded a patent in the United States for an Alkyne Trapping Method. The process can couple various alkynes with indenes in water leading to high value chemicals that can be used by different chemical industries.
WRN Chemical protects chemical process technology with a United States patent that can manufacture chemicals that can be used by the oil and gas industry.
WRN Chemical awarded a United States patent for a high value chemical process that can manufacture pharmaceutical intermediates.
WRN Chemical awarded a patent in Switzerland for a chemical process that leads to pharmaceuticals that can treat and prevent HIV.
WRN Chemical continues with patenting activities in Switzerland for several chemical process technologies.
WRN Chemical secures licensing rights for a new infectious disease technology portfolio from a Canadian university.
President and CEO of WRN Chemical attends 2014 National Fluids Technical Conference in Houston, Texas and meets with oil and gas producers to discuss new technology opportunities.
WRN Chemical welcomes our new legal director to manage technology licensing and other legal activities.
WRN Chemical obtains assignment and licensing rights for a new process technology that leads to high value products from a Canadian university.
WRN Chemical initiates patent application for a new HIV therapeutics technology platform.
WRN Chemcal strengthens technology portfolio by initiating three patent applications for new pharmaceutical technologies.
WRN Chemcal licenses new chemical process to a Canadian technology company.
President secures assignment and licensing rights of intellectual property for new chemical process technologies from a Canadian university that can manufacture chemicals used by different industries.
President secures assignment and licensing rights of intellectual property for green chemical technologies from a Canadian university.
President attends 243rd Annual American Chemical Society meeting in San Diego, USA.
Intellectual property for new pharmaceutical chemical processes is being negotiated for assignment from current inventor.
President attends FROST 3 conference in Budapest Hungary to discuss partnerships with providers of microreactor technology.
President attends 94th Canadian Chemistry Conference and Exhibition in Montreal, Canada.
WRN Chemical announces new team members to join accounting and legal departments.
WRN Chemical develops new chemical processes for products applicable to the oil, and pharmaceutical industry.
President attends 93rd Canadian Chemistry Conference and Exhibition in Toronto, Canada.
President attends 92nd Canadian Chemistry Conference and Exhibition in Hamilton, Canada.